Details of the Drug

General Information of Drug (ID: DMU7ZMH)

Drug Name
S-364735
Synonyms GSK-364735; HIV integrase inhibitors (2), Shionogi/GlaxoSmithKline
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 2 [1]
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
54718859
UNII
SXN0KXT60S
DrugBank ID
DB13119
TTD ID
D09HOW

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Integrase (HIV IN) TT5FH9Y POL_HV1B1 Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00398125) Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults. U.S. National Institutes of Health.
2 The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. Antimicrob Agents Chemother. 2008 Mar;52(3):901-8.